Last Call ......not wake up call. When LTAT pushing DKSH share price lower to transfer share or change hand, immediately we also follow to collect at lower price. That is the only way we can buy at cheaper price.
DKSH provides clinical trial logistics services to Nordic Bioscience in Hong Kong
12.12.2013 | DKSH, the leading Market Expansion Services provider with a focus on Asia, has signed an agreement with Nordic Bioscience, an international biotech organization, to offer clinical trial logistics services in Hong Kong.
Hong Kong, December 12, 2013 – DKSH’s Business Unit Healthcare, the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia, has signed an agreement with Nordic Bioscience to provide clinical trial logistics services in Hong Kong. Under the agreement, DKSH is responsible for the importation of investigational products, products storage, delivery, return and destruction.
“Hong Kong has excellent infrastructure in terms of transportation, workforce and legal framework for conducting clinical trials. What we need is to find a partner which can offer clinical trial logistics services in a safe manner with high security and reliability,” said Jeppe Ragnar Andersen, Head of Clinical Development, Nordic Bioscience. “We are happy to work with DKSH Hong Kong. Its specialized clinical trial team should help us ensure that the logistics of our trials are managed with the expertise and quality we demand.”
“Our company is certified to comply with international standards (ISO, GMP, GDP), ensuring our clients peace of mind on storage and service execution. Our distribution center environment together with our talented team offer the best possible solution for clinical trial logistics services in Hong Kong,” said Richard Holloway, Vice President, DKSH Healthcare, Hong Kong. “The number of clinical trials in Asia has been increasing steadily. We are seeing rising demands and referrals from clinical research organizations on clinical trial logistics services in Hong Kong. This value-added service poised great business potential in addition to our traditional offerings.”
The new partnership will further strengthen DKSH’s market position in healthcare in Hong Kong while contributing incrementally to the Group’s overall profitability over time.
About Nordic Bioscience
Nordic Bioscience is an international biotech organization with research facilities in Copenhagen, Denmark, and in Beijing, China. The company comprises three divisions: Biomarkers & Research, Clinical Develop-ment, and the Laboratory. It is a group with the capacity and specialist expertise to develop protocols for, manage, and support studies ranging from those in early preclinical phases to the pivotal phase IIIs required for marketing authorization.
About DKSH
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term “Market Expansion Services” suggests, DKSH helps other companies and brands to grow their business in new or existing markets.
Publicly listed on the SIX Swiss Exchange since March 2012, DKSH is a global company headquartered in Zurich. With 680 business locations in 35 countries – 660 of them in Asia – and 25,900 specialized staff, DKSH generated net sales of CHF 8.8 billion in 2012.
DKSH Business Unit Healthcare is the leading Market Expansion Ser-vices provider for healthcare companies seeking to grow their business in Asia. Custom-made offerings comprise registration and market entry studies as well as importation, customs clearance, marketing and sales to physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include ethical pharmaceuticals, consumer health, over-the-counter (OTC), as well as medical devices.
With 150 business locations in 13 countries and around 8,270 specialized staff, Business Unit Healthcare serves over 160,000 customers and gen-erated net sales of around CHF 3.7 billion in 2012.
Based on the attached bursa report and DKSH pdf file. The company has a good control of debt level and with healthy cash flow.
DISPOSAL OF ALL THAT PIECE OF LEASEHOLD LAND MEASURING APPROXIMATELY 258,746 SQ. FT. AND HELD UNDER PAJAKAN NEGERI 3696, LOT 52 SEKSYEN 13, BANDAR PETALING JAYA, DAERAH PETALING, NEGERI SELANGOR TOGETHER WITH THE OFFICE AND INDUSTRIAL BUILDINGS AND WAREHOUSES ERECTED THEREON BY DKSH CENTRAL SERVICES MALAYSIA SDN BHD TO SUN-PJDC SDN BHD FOR A TOTAL CASH CONSIDERATION OF RM124,200,000.00
Estimated gain from the Proposed Disposal RM96,234,000 Proforma profit attributable to owners of the Company after the Proposed Disposal RM174,746,000 EPS = 110.84
Lembaga Tabung Angkatan Tentera (LTAT) 18/12/13 - Disposed 145,800 shares 19/12/13 - Disposed 283,600 shares 20/12/13 - Disposed 1,109,300 shares
year 2011 - LTAT 16,701,800 shares 10.59% year 2012 - LTAT 13,467,600 shares 8.54% 20/12/13 - LTAT 8,907,400 shares 5.65%
Every time when LTAT selling, there is a ready buyer.....Willing buy willing sell with an agreed price and period. So who is the person collecting LTAT shares??? and why ???
I believe long term investor with holding power will always win. DKSH is a very good company.
Higher liquidity allows more to invest in DKSH The changes in LTAT’s shareholding have improved its liquidity, giving opportunities for other investors and even institutional funds to buy into the company.
DKSH shares 74% held by its parent via DKSH Resources (M) Sdn Bhd
Lembaga Tabung Angkatan Tentera (LTAT) - the money is from Tentera, Military, defence department. LTAT selling or transfered share to ??? New major shareholder could be Big Fund Managers or YB, Datuk Seri, Tan Seri or even Tun. Anything is possible.
Very high volume almost everyday, 26/12/2013 - 789,000 24/12/2013 - 1,618,500 23/12/2013 - 645,200 today until noon - 956,800 I hope LTAT sell or transfer all their shares before Q4'13 result announce in mid Feb'14. Q4'13 and total 2013 profit should be very very good compare to previous year. Estimate EPS more than RM1.50 including profit on sale of land.
According to DKSH report . EPS from disposal of land = RM1.10. (if I am not wrong) Could you please double check from bursa announcement. If include Earning for the whole year, should be more than RM1.50, May be even more than that.
If you monitor everyday, You will know that a lot of trading volume and changing hand for the past few days with agreed price and time. Passing the ball from A to B or C. We don't know when this is going the complete. Based on 27/12/13 - LTAT has reduce it share to from last year 13,000,000 to 8,181,400 shares. from 28 to 31/12/13 another 5,000,000 shares change hand. Sooner or later, it's going to end. Then DKSH share will be more stable and showing true potential.
LTAT 27/12/2013 - Disposal 1,497,000 shares. LTAT is no more the Substantial shareholder of DKSH. (Yesterday Bursa news) Notice of Person Ceasing to be a Substantial Shareholder Pursuant to Form 29C of the Companies Act. 1965 Higher liquidity is good for DKSH with added new Fund Managers.
New IPO: Building management systems (BMS), solar thermal systems and energy-saving services provider, Solar District Cooling Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
neohts
2,312 posts
Posted by neohts > 2013-12-19 14:16 | Report Abuse
I hope Bonus 1 for 1......Kong Xi Fa Cai....Happy New Year